Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Book/Report

Prescription Opioids: Medicare Needs to Expand Oversight Efforts to Reduce the Risk of Harm.

Prescription Opioids: Medicare Needs to Expand Oversight Efforts to Reduce the Risk of Harm. Washington, DC: United States Government Accountability Office; October 2017. Publication GAO-18-15.

Save
Print
November 22, 2017
Washington, DC: United States Government Accountability Office; October 2017. Publication GAO-18-15.

Opioid prescribing is under increased scrutiny in an effort to address opioid misuse. Examining Medicare Part D prescription trends, this report recommends that the Centers for Medicare and Medicaid Services collect more data on beneficiaries receiving high doses of opioids and the clinicians who prescribe them and advocates for increased reporting of clinicians who inappropriately prescribe opioids. An Annual Perspective discussed the opioid epidemic as a patient safety problem.

Save
Print
Cite
Citation

Prescription Opioids: Medicare Needs to Expand Oversight Efforts to Reduce the Risk of Harm. Washington, DC: United States Government Accountability Office; October 2017. Publication GAO-18-15.